134 related articles for article (PubMed ID: 7025545)
61. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
Lan NC; Matulich DT; Stockigt JR; Biglieri EG; New MI; Winter JS; McKenzie JK; Baxter JD
Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
[No Abstract] [Full Text] [Related]
62. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
Azibani F; Benard L; Schlossarek S; Merval R; Tournoux F; Fazal L; Polidano E; Launay JM; Carrier L; Chatziantoniou C; Samuel JL; Delcayre C
Hypertension; 2012 Jun; 59(6):1179-87. PubMed ID: 22547442
[TBL] [Abstract][Full Text] [Related]
63. [Primary hyperaldosteronism suppressed after glucocorticoid administration].
Brzezińska A; Słowińska-Srzednicka J; Wieteska-Klimczak A; Wyszyńska T; Januszewicz P
Endokrynol Pol; 1992; 43(3):330-5. PubMed ID: 1345573
[TBL] [Abstract][Full Text] [Related]
64. Are idiopathic hyperaldosteronism and low-renin hypertension variants of essential hypertension?
Brown JJ; Lever AF; Robertson JI; Beevers DG; Cumming AM; Davies DL; Fraser R; Mason P; Morton JJ; Tree M
Ann Clin Biochem; 1979 Nov; 16(6):380-8. PubMed ID: 395890
[No Abstract] [Full Text] [Related]
65. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
[TBL] [Abstract][Full Text] [Related]
66. [New data on mineralocorticoid hormones. Physiopathological implications].
Corvol P; Jeunemaitre X
Presse Med; 1995 Sep; 24(27):1235-7. PubMed ID: 7501603
[TBL] [Abstract][Full Text] [Related]
67. Rectal potential difference in the diagnosis of aldosterone excess.
Beevers DG; Morton JJ; Tree M; Young J
Gut; 1975 Jan; 16(1):36-41. PubMed ID: 237802
[TBL] [Abstract][Full Text] [Related]
68. The contribution of the zona fasciculata and glomerulosa to plasma 11-deoxycorticosterone levels in man.
Tan SY; Mulrow PJ
J Clin Endocrinol Metab; 1975 Jul; 41(1):126-30. PubMed ID: 168227
[TBL] [Abstract][Full Text] [Related]
69. Plasma immunoreactive proopiolipomelanocortin-derived peptides in patients with primary hyperaldosteronism, idiopathic hyperaldosteronism with bilateral adrenal hyperplasia, and dexamethasone-suppressible hyperaldosteronism.
Güllner HG; Nicholson WE; Gill JR; Orth DN
J Clin Endocrinol Metab; 1983 Apr; 56(4):853-5. PubMed ID: 6300169
[TBL] [Abstract][Full Text] [Related]
70. Low-renin hypertension in young infants.
Field ML; Roy S; Stapleton FB
Am J Dis Child; 1985 Aug; 139(8):823-5. PubMed ID: 3895890
[TBL] [Abstract][Full Text] [Related]
71. Familial hyperaldosteronism.
Torpy DJ; Stratakis CA; Chrousos GP
Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
[TBL] [Abstract][Full Text] [Related]
72. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
Griffing GT; Dale SL; Holbrook MM; Melby JC
J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
[TBL] [Abstract][Full Text] [Related]
73. Effect of standard oral glucose loading on aldosterone secretion in primary hyperaldosteronism.
Beretta-Piccoli C; Weidmann P; Brown JJ; Fraser R; Lever AF; Marone C; Robertson JI
Acta Endocrinol (Copenh); 1982 Sep; 101(1):66-71. PubMed ID: 6751010
[TBL] [Abstract][Full Text] [Related]
74. Dexamethasone suppressible hyperaldosteronism: insights into adrenal physiology.
Connell JM; Jardine A; Fraser R
Adv Nephrol Necker Hosp; 1990; 19():69-77. PubMed ID: 2154082
[No Abstract] [Full Text] [Related]
75. Aldosterone and other mineralocorticoids in Bartter's syndrome.
Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
[TBL] [Abstract][Full Text] [Related]
76. Hyperaldosteronism in the sodium-depleted rat: mode of aldosterone-stimulating action of frusemide.
Spät A; Tarján E; Tóth G
J Endocrinol; 1979 Jul; 82(1):7-15. PubMed ID: 479736
[TBL] [Abstract][Full Text] [Related]
77. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
78. Abnormalities of aldosterone synthesis and action in children.
White PC
Curr Opin Pediatr; 1997 Aug; 9(4):424-30. PubMed ID: 9300202
[TBL] [Abstract][Full Text] [Related]
79. Dexamethasone-suppressible hypertension.
Stewart PM
Lancet; 2000 Aug; 356(9231):697-9. PubMed ID: 11085685
[No Abstract] [Full Text] [Related]
80. [The effect of cortisol infusion on plasma renin activity, aldosterone levels and 11-deoxycorticosterone levels in humans (author's transl)].
Sugawara T
Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):710-8. PubMed ID: 689214
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
